DMAC

Companies
NASDAQ
DiaMedica Therapeutics Inc.
Health Care
Price Chart
Overview

About DMAC

diamedica therapeutics is a clinical-stage biopharmaceutical company that is developing innovative treatments where there is significant unmet clinical need or where no current therapies are available with the focus on neurological and kidney diseases. for more information please visit www.diamedica.com.

Market Cap
$97.2M
Volume
440.9K
Avg. Volume
358.4K
P/E Ratio
-5.587838
Dividend Yield
0.00%
Employees
39.0

Company Information

Exchange
NASDAQ
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.67
Low Correlation
Volatility
High (0.75)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for DMAC.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, DMAC shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$97.2M
Volume440.9K
P/E Ratio-5.59
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 14, 2025
Related Securities

PortfolioPilot Analysis

Get AI-powered insights on how DMAC fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025